Drug Development

Articles

Catalent combines its formulation expertise, manufacturing excellence and particle size reduction technologies to provide a broad range of solutions in the development of inhalation and nasal drug products.

Manufacturing and Formulation Solutions for Inhaled Dose Forms

Companies believe that biologics and biosimilars would experience the fastest growth over the next year; there is also interest on increasing market penetration of generic drugs.

Growth of Japanese Pharma Market Driven by Biologics and Generic Drugs, Says CPhI Report

Sandoz, a Novartis division, announced  that the Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions recommending the approval of its biosimilars rituximab and  etanercept in Europe, for the same indications as the respective reference medicines.

Sandoz’s Rituximab and Etanercept Biosimilars Recommended for European Approval

In implementing quality by design for drug formulation, it is crucial to identify the critical properties of excipients and understand how their variation affects the final drug product.

Understanding How Excipients Affect Drug Quality

The funding allows the company to broaden its range of services and finance its move to new laboratory facilities in the Illkirch-Graffenstaden innovation park in northeast France.

Inoviem Scientific Secures Funding to Finance Expansion

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Pharmaceutical Technology spoke with CPhI North America presenter Jonathan Helfgott to discuss navigating GDUFA and helpful tips for submitting successful ANDAs.

Former CDER OSI Associate Director for Risk Science to Speak at CPhI North America 2017

The project will foster the translation of nanomedicine applications for the treatment of cardiovascular diseases.

Nemera Joins European Project to Develop Inhaled Nanoparticles for Heart Disease

The agency issued its recommendation for the influenza virus strains European vaccine manufacturers should include for 2017.

EMA Updates Flu Vaccination Recommendations

In a new study, researchers from Boston Children’s Hospital study responses to pneumococcal vaccine in infant monkeys.

Researchers Study Vaccine Responses in Newborns

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Researchers continue efforts to overcome challenges of effective oral delivery of biologic drugs.

Formulation and Drug Delivery